Igc Pharma, Inc.
IGC
Revenue
272.00k
▼-23.00k▼-7.80%
3 Months ChangeAssets
10.59M
▲692.00k▲6.99%
3 Months ChangeLiabilities
2.71M
▲133.00k▲5.15%
3 Months ChangeFree Cash Flow
-1.79M
▼-302.00k▼-20.30%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-27
Form 8-K
ID: 0001185185-24-000923
2024-08-27
Form 8-K
ID: 0001185185-24-000851
2024-08-07
Form 10-Q
ID: 0001185185-24-000766
2024-08-02
Form 8-K
ID: 0001185185-24-000755
2024-04-05
Form 8-K
ID: 0001185185-24-000360
2024-03-28
Form 8-K
ID: 0001185185-24-000324
2024-03-22
Form 8-K
ID: 0001185185-24-000301
2024-03-13
Form 8-K
ID: 0001185185-24-000233
2024-02-14
Form 10-Q
ID: 0001185185-24-000160
2023-11-09
Form 10-Q
ID: 0001185185-23-001163